Literature DB >> 11552195

Maggot débridement therapy in outpatients.

R A Sherman1, J Sherman, L Gilead, M Lipo, K Y Mumcuoglu.   

Abstract

OBJECTIVE: To identify the benefits, risks, and problems associated with outpatient maggot therapy.
DESIGN: Descriptive case series, with survey.
SETTING: Urban and rural clinics and homes. PARTICIPANTS: Seven caregivers with varying levels of formal health care training and 21 ambulatory patients (15 men, 6 women; average age, 63 yr) with nonhealing wounds. INTERVENTION: Maggot therapy. MAIN OUTCOME MEASURE: Therapists' opinions concerning clinical outcomes and the disadvantages of therapy.
RESULTS: More than 95% of the therapists and 90% of their patients were satisfied with their outpatient maggot débridement therapy. Of the 8 patients who were advised to undergo amputation or major surgical débridement as an alternative to maggot débridement, only 3 required surgical resection (amputation) after maggot therapy. Maggot therapy completely or significantly débrided 18 (86%) of the wounds; 11 healed without any additional surgical procedures. There was anxiety about maggots escaping, but actual escapes were rare. Pain, reported by several patients, was controlled with oral analgesics.
CONCLUSIONS: Outpatient maggot débridement is safe, effective, and acceptable to most patients, even when administered by nonphysicians. Maggot débridement is a valuable and rational treatment option for many ambulatory, home-bound, and extended care patients who have nonhealing wounds.

Entities:  

Mesh:

Year:  2001        PMID: 11552195     DOI: 10.1053/apmr.2001.24300

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  9 in total

1.  Assessment of the antimicrobial properties of maggots.

Authors:  Leon Margolin; Philip Gialanella
Journal:  Int Wound J       Date:  2010-04-23       Impact factor: 3.315

2.  Functional reconstruction of the diabetic foot.

Authors:  Mark W Clemens; Christopher E Attinger
Journal:  Semin Plast Surg       Date:  2010-02       Impact factor: 2.314

Review 3.  Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century.

Authors:  Ronald A Sherman
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

4.  Survey of patients of the Tver region of Russia regarding maggots and maggot therapy.

Authors:  Artem M Morozov; Ronald A Sherman
Journal:  Int Wound J       Date:  2018-12-13       Impact factor: 3.315

5.  Therapeutic effects of Lucilia sericata larval excretion/secretion products on Leishmania major under in vitro and in vivo conditions.

Authors:  Jila Sherafati; Mohammad Saaid Dayer; Fatemeh Ghaffarifar
Journal:  Parasit Vectors       Date:  2022-06-16       Impact factor: 4.047

6.  Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.

Authors:  Aaron G Paul; Nazni W Ahmad; H L Lee; Ashraff M Ariff; Masri Saranum; Amara S Naicker; Zulkiflee Osman
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

7.  Large leg ulcers due to autoimmune diseases.

Authors:  Alexander P Rozin; Dana Egozi; Yehuda Ramon; Kohava Toledano; Yolanda Braun-Moscovici; Doron Markovits; Daniel Schapira; Reuven Bergman; Yehuda Melamed; Yehuda Ullman; Alexandra Balbir-Gurman
Journal:  Med Sci Monit       Date:  2011-01

8.  Maggot debridement: an alternative method for debridement.

Authors:  Finn Gottrup; Bo Jørgensen
Journal:  Eplasty       Date:  2011-07-12

9.  Adjunct methods of the standard diabetic foot ulceration therapy.

Authors:  Dariusz Waniczek; Andrzej Kozowicz; Małgorzata Muc-Wierzgoń; Teresa Kokot; Elżbieta Swiętochowska; Ewa Nowakowska-Zajdel
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-13       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.